244 related articles for article (PubMed ID: 26044462)
1. Blinding in pharmaceutical clinical trials: An overview of points to consider.
Crisp A
Contemp Clin Trials; 2015 Jul; 43():155-63. PubMed ID: 26044462
[TBL] [Abstract][Full Text] [Related]
2. Blinding in randomized clinical trials: imposed impartiality.
Hróbjartsson A; Boutron I
Clin Pharmacol Ther; 2011 Nov; 90(5):732-6. PubMed ID: 21993424
[TBL] [Abstract][Full Text] [Related]
3. Who is blinded in randomized clinical trials? A study of 200 trials and a survey of authors.
Haahr MT; Hróbjartsson A
Clin Trials; 2006; 3(4):360-5. PubMed ID: 17060210
[TBL] [Abstract][Full Text] [Related]
4. Blinding strategies in the conduct and reporting of a randomized placebo-controlled device trial.
Houweling AH; Shapiro S; Cohen JM; Kahn SR
Clin Trials; 2014 Oct; 11(5):547-52. PubMed ID: 24902921
[TBL] [Abstract][Full Text] [Related]
5. The blind leading the blind: use and misuse of blinding in randomized controlled trials.
Miller LE; Stewart ME
Contemp Clin Trials; 2011 Mar; 32(2):240-3. PubMed ID: 21070890
[TBL] [Abstract][Full Text] [Related]
6. Blinded trials taken to the test: an analysis of randomized clinical trials that report tests for the success of blinding.
Hróbjartsson A; Forfang E; Haahr MT; Als-Nielsen B; Brorson S
Int J Epidemiol; 2007 Jun; 36(3):654-63. PubMed ID: 17440024
[TBL] [Abstract][Full Text] [Related]
7. Reporting on blinding in trial protocols and corresponding publications was often inadequate but rarely contradictory.
Hróbjartsson A; Pildal J; Chan AW; Haahr MT; Altman DG; Gøtzsche PC
J Clin Epidemiol; 2009 Sep; 62(9):967-73. PubMed ID: 19635403
[TBL] [Abstract][Full Text] [Related]
8. Is it possible to blind a trial for community-acquired pneumonia?
Boucher HW
Clin Infect Dis; 2008 Dec; 47 Suppl 3():S210-5. PubMed ID: 18986292
[TBL] [Abstract][Full Text] [Related]
9. In the dark: the reporting of blinding status in randomized controlled trials.
Montori VM; Bhandari M; Devereaux PJ; Manns BJ; Ghali WA; Guyatt GH
J Clin Epidemiol; 2002 Aug; 55(8):787-90. PubMed ID: 12384193
[TBL] [Abstract][Full Text] [Related]
10. Turning a blind eye: the success of blinding reported in a random sample of randomised, placebo controlled trials.
Fergusson D; Glass KC; Waring D; Shapiro S
BMJ; 2004 Feb; 328(7437):432. PubMed ID: 14761905
[TBL] [Abstract][Full Text] [Related]
11. Assessment of blinding in clinical trials.
Bang H; Ni L; Davis CE
Control Clin Trials; 2004 Apr; 25(2):143-56. PubMed ID: 15020033
[TBL] [Abstract][Full Text] [Related]
12. Reporting methods of blinding in randomized trials assessing nonpharmacological treatments.
Boutron I; Guittet L; Estellat C; Moher D; Hróbjartsson A; Ravaud P
PLoS Med; 2007 Feb; 4(2):e61. PubMed ID: 17311468
[TBL] [Abstract][Full Text] [Related]
13. Methods of blinding in reports of randomized controlled trials assessing pharmacologic treatments: a systematic review.
Boutron I; Estellat C; Guittet L; Dechartres A; Sackett DL; Hróbjartsson A; Ravaud P
PLoS Med; 2006 Oct; 3(10):e425. PubMed ID: 17076559
[TBL] [Abstract][Full Text] [Related]
14. Blinding during data analysis and writing of manuscripts.
Gøtzsche PC
Control Clin Trials; 1996 Aug; 17(4):285-90; discussion 290-3. PubMed ID: 8889343
[No Abstract] [Full Text] [Related]
15. An index for assessing blindness in a multi-centre clinical trial: disulfiram for alcohol cessation--a VA cooperative study.
James KE; Bloch DA; Lee KK; Kraemer HC; Fuller RK
Stat Med; 1996 Jul; 15(13):1421-34. PubMed ID: 8841652
[TBL] [Abstract][Full Text] [Related]
16. Specific instructions for estimating unclearly reported blinding status in randomized trials were reliable and valid.
Akl EA; Sun X; Busse JW; Johnston BC; Briel M; Mulla S; You JJ; Bassler D; Lamontagne F; Vera C; Alshurafa M; Katsios CM; Heels-Ansdell D; Zhou Q; Mills E; Guyatt GH
J Clin Epidemiol; 2012 Mar; 65(3):262-7. PubMed ID: 22200346
[TBL] [Abstract][Full Text] [Related]
17. A theoretical analysis showed that blinding cannot eliminate potential for bias associated with beliefs about allocation in randomized clinical trials.
Mathieu E; Herbert RD; McGeechan K; Herbert JJ; Barratt AL
J Clin Epidemiol; 2014 Jun; 67(6):667-71. PubMed ID: 24767518
[TBL] [Abstract][Full Text] [Related]
18. Pre-trial evaluation of the potential for unblinding in drug trials: a prototype example.
Walter SD; Awasthi S; Jeyaseelan L
Contemp Clin Trials; 2005 Aug; 26(4):459-68. PubMed ID: 16054578
[TBL] [Abstract][Full Text] [Related]
19. A review of blinding in randomized controlled trials found results inconsistent and questionable.
Boutron I; Estellat C; Ravaud P
J Clin Epidemiol; 2005 Dec; 58(12):1220-6. PubMed ID: 16291465
[TBL] [Abstract][Full Text] [Related]
20. Double-blinding of an acupuncture randomized controlled trial optimized with clinical translational science award resources.
Steffen AD; Burke LA; Pauls HA; Suarez ML; Yao Y; Kobak WH; Takayama M; Yajima H; Kaptchuk TJ; Takakura N; Wilkie DJ; Schlaeger JM
Clin Trials; 2020 Oct; 17(5):545-551. PubMed ID: 32650673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
